Zembrin is a patented extract of Sceletium tortuosum.
Supplements brand NOW has launched a new product, Calm & Focus, which features PLT Health Solutions’ (Morristown, NJ) patented Zembrin Sceletium tortuosum ingredient as well as gamma-aminobutyric acid (GABA). The supplement aims to support relaxation, focus, and mental functioning.
According to a PLT Health Solutions press release, Zembrin has been clinically studied to demonstrate that it reduces stress and enhances mood and has been shown to start working in as little as two hours after ingestion.
The Calm & Focus product contains 25 mg of Zembrin and 300 mg of GABA. In a press release, NOW’s vitamin brand manager, Kim Perkins, pointed to the clinical evidence supporting Zembrin’s efficacy.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.